ARCHIVES

Skipper’s Impact: Drugs Curing 40,000 a Year

This article is from The Cancer Letter archive.

Vol. 07 No. 13 | March 27, 1981

Download PDF Visit The Full Archive

Related Articles

NCI Plans To Recomplete CCOP; Future Direction To Be Discuss At DCPC Board, NCAB Meetings

January 17, 1986

Risk of Lymphoma Increases with Hepatitis C Virus Infection

May 25, 2007

New Agents, New Approaches Benefit Treatment Of Advanced Lung Cancer

August 29, 2003

Switching to Tasigna After Gleevec Therapy Can Achieve Deeper Molecular Response

December 28, 2012

NCAB Discussion Of Working Group Report

February 28, 2003

Enter The Cancer Letter’s 35th Anniversary Story Contest

July 31, 2009